Latest News from: Wistar Institute

Add to Favorites Subscribe Share
newswise-fb-share-
Newswise: Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China

Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China

Wistar Institute

Wistar announces today that they are part of a team to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has infected hundreds in China and other countries, including the U.S., and resulted in numerous deaths to date. Wistar is part of a collaboration funded by the Coalition for Epidemic Preparedness Innovations (CEPI).

Channels: Cell Biology, Infectious Diseases, Public Health, China News,

Released:
23-Jan-2020 1:50 PM EST
Newswise: The Wistar Institute Received Nearly $2.5M in Philanthropic Support

The Wistar Institute Received Nearly $2.5M in Philanthropic Support

Wistar Institute

In the past six months, scientists at The Wistar Institute received funding from private foundations totaling $2,418,000 that will fuel new discoveries in cancer, immunology and infectious diseases.

Channels: Cancer, Immunology, Infectious Diseases, Grant Funded News,

Released:
19-Dec-2019 4:20 PM EST
Announcement
Newswise: New Therapeutic Strategy for Chemotherapy Resistance in Ovarian Cancer

New Therapeutic Strategy for Chemotherapy Resistance in Ovarian Cancer

Wistar Institute

A Wistar study demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment.

Channels: All Journal News, Cancer, Drug Resistance, OBGYN, Pharmaceuticals, Women's Health,

Released:
19-Dec-2019 10:40 AM EST
Announcement
Newswise: Microscopic World Comes Alive During Nikon Small World Exhibit

Microscopic World Comes Alive During Nikon Small World Exhibit

Wistar Institute

See cellular images as distinct as abstract art, minerals appear as future urban landscapes, single-celled organisms of the microscopic netherworld, and much more from the 2019 Nikon Small World competition of photomicrography.

Channels: Cancer, Healthcare, In the Workplace, Infectious Diseases, Media and Journalism,

Released:
17-Dec-2019 3:55 PM EST
Research Results
Newswise: International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

Wistar Institute

Wistar and Leiden University Medical Center (LUMC) formalized a memorandum of understanding between the two institutions to explore a postdoctoral training exchange program in immunology, cancer research and vaccine biology. The Wistar-Schoemaker International Postdoctoral Fellowship would bring recent Ph.D. graduates trained at LUMC to Wistar to advance their research education under the mentorship of cutting-edge biomedical research leaders.

Channels: All Journal News, Cancer, Education, Healthcare, Immunology, Technology, Vaccines,

Released:
15-Nov-2019 1:40 PM EST
Announcement

Synthetic DNA Technology Applied as a Novel Strategy for Delivery of Anti-HIV Antibodies

Wistar Institute

Wistar scientists applied synthetic DNA-based technology to drive in vivo production of broadly neutralizing anti-HIV antibodies in small and large-animal models, providing proof of concept for a simple and effective next generation approach to HIV prevention and therapy. These results were published online in the Journal of Clinical Investigation.

Channels: AIDS and HIV, All Journal News, Healthcare, Technology,

Released:
8-Nov-2019 12:50 PM EST
Announcement
Newswise: Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Wistar Institute

The American Cancer Society has awarded a Research Professorship to Wistar's Dmitry l. Gabrilovich, M.D., Ph.D. This lifelong designation, accompanied by a five-year $400,000 commitment, is the most prestigious research grant made by ACS.

Channels: Cancer,

Released:
22-Oct-2019 10:30 AM EDT
Research Results
Newswise: $12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

Wistar Institute

Wistar and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and development of resistance.

Channels: Cancer, National Institutes of Health (NIH),

Released:
17-Oct-2019 9:40 AM EDT
Announcement
Newswise: New Mechanism Fueling Brain Metastasis Discovered at Wistar

New Mechanism Fueling Brain Metastasis Discovered at Wistar

Wistar Institute

Wistar scientists described a novel mechanism through which astrocytes, the most abundant supporting cells in the brain, also promote cancer cell growth and metastasis in the brain.

Channels: Cancer, All Journal News,

Released:
9-Oct-2019 11:05 AM EDT
Announcement
Newswise: Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies
  • Embargo expired:
    3-Oct-2019 10:00 AM EDT

Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies

Wistar Institute

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.

Channels: All Journal News, Cancer, Cell Biology,

Released:
2-Oct-2019 3:05 PM EDT
Research Results


0.80717